NightHawk Biosciences, Inc.·4

Dec 9, 5:03 PM ET

Wolf Jeffrey Alan 4

4 · NightHawk Biosciences, Inc. · Filed Dec 9, 2022

Insider Transaction Report

Form 4
Period: 2022-12-07
Wolf Jeffrey Alan
DirectorChief Executive Officer10% Owner
Transactions
  • Award

    Stock Option (right to buy)

    2022-12-07+2,843,1372,843,137 total
    Exercise: $1.02From: 2023-01-03Exp: 2032-12-07Common Stock (2,843,137 underlying)
Footnotes (1)
  • [F1]The options vest 1/3 January 3, 2023 and the balance vests monthly on a pro rata basis over thirty-six months.

Documents

1 file
  • 4
    wolf4.xmlPrimary

    OWNERSHIP DOCUMENT